tbuckley/cabot-search huggingface dataset:
THE CONTENT OF VITAMINS A AND D IN COD LIVER OIL
Journal: JAMA (1928)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Cases in the Hospital Practice of T. M. Greenhow, Esq., Senior Surgeon to the Newcastle-On-Tyne Infirmary
Authors: C. J. Gibb
Journal: BMJ (1846)

by cautiously applying a little sulphuric acid across the centre of tthe eyelid.When the shape of the tarsal cartilage is altered, othier plans .renecessary.Trichiasis.-Remove the iniverted cilia wiLl forceps, or pair off the edges of thkc eyelids, including the bulbs of the eyelashes.Granular Conjanctiva.-Evert the lid, and apply witlh a camel's hair-pencil, mnelted unguientiiut hydrargyri nitratis, or solutio arg,enti nitratis rgr.xx-xxx-oz.j.;) or ruib it with sulphiate of copper or nitrate of silver.The eyelid milust be bathed with tepid water before it is returned to its natural position.In somie cases excision of the callosities is desirable.Concretion of the Eyelids.-Divide the adlhesion witi a knife, guided on a director.Lachrymal Organs.Enlargement, &c., of the gland, may be treated witlh alterative miedicines, iodine frictions, &c.Enaanthis.-Astringentapplications, and sometimes excision, Inflammation of the Lachrymal Sac.-Deplete, and ise emiollient applications, &c.If resolution is not practicable, we should puinctuire the sac, and inject tepid water with Anel's syringe.If the nasal duct is
LABIOMYCOSIS
Authors: WILLMOTT EVANS
Journal: British Journal of Dermatology (1903)

Journal Article LABIOMYCOSIS Get access WILLMOTT EVANS, M.D., F.R.C.S. WILLMOTT EVANS, M.D., F.R.C.S. Surgeon to the Skin Department, Royal Free Hospital Search for other works by this author on: Oxford Academic Google Scholar British Journal of Dermatology, Volume 15, Issue 9, 1 September 1903, Pages 319–322, https://doi.org/10.1111/j.1365-2133.1903.tb16520.x Published: 01 September 1903
The Heart in Pregnancy and the Childbearing Age
Journal: JAMA (1941)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Status Epilepticus
Authors: Charles F. Nicol
Journal: JAMA (1975)

STATUS epilepticus rarely occurs as the initial manifestation of an idiopathic epileptic disorder or in a patient whose seizures have been effectively controlled for a long time. Far too often, it follows the sudden cessation of maintenance therapy; there is no justification, therefore, for stopping medication before obtaining an electroencephalogram. Other causes of status epilepticus include infection, which is not necessarily confined to the central nervous system, occlusive cerebral vascular disease, metabolic and hypertensive encephalopathies, primary and secondary brain tumors, head trauma, degenerative central nervous system diseases of obscure origin, and, rarely, systemic diseases including the collagen diseases. Diagnosis of the type of status epilepticus is usually made by history and by observation of at least one seizure. Because the patient loses consciousness in major motor epilepsy, the testimony of a competent witness is necessary. In focal motor epilepsy, the patient may remain conscious during a seizure and is thus
The Medical Management of Arterial Hypertension
Authors: Edward Meilman
Journal: New England Journal of Medicine (1953)

Potassium Thiocyanate and Sodium Nitroprusside Since Barker,124 in 1936, demonstrated that many of the toxic effects of thiocyanate administration could be controlled by measurement of the blood level, the use of this drug in hypertension has had some acceptance. The necessity of serum level determinations at intervals of two to four weeks has limited its use, but it has been recommended,125 especially for control of hypertensive headaches. It has been reported to have increased effectiveness after sympathectomy.125 A recent revival of interest127 has followed the suggestion that thiocyanate exerts its hypotensive behavior through some hormonal mechanism rather than some nonspecific . . .
Lead Loading of Urban Streets by Motor Vehicle Wheel Weights
Authors: Robert A. Root
Journal: Environmental Health Perspectives (2000)

This study documents that lead weights, which are used to balance motor vehicle wheels, are lost and deposited in urban streets, that they accumulate along the outer curb, and that they are rapidly abraded and ground into tiny pieces by vehicle traffic. The lead is so soft that half the lead deposited in the street is no longer visible after little more than 1 week. This lead loading of urban streets by motor vehicle wheel weights is continuous, significant, and widespread, and is potentially a major source of human lead exposure because the lead is concentrated along the outer curb where pedestrians are likely to step. Lead deposition at one intersection in Albuquerque, New Mexico, ranged from 50 to 70 kg/km/year (almost 11 g/ft(2)/year along the outer curb), a mass loading rate that, if accumulated for a year, would exceed federal lead hazard guidelines more than 10,000 times. Lead loading of major Albuquerque thoroughfares is estimated to be 3,730 kg/year. Wheel weight lead may be dispersed as fugitive dust, flushed periodically by storm water into nearby waterways and aquatic ecosystems, or may adhere to the shoes of pedestrians or the feet of pets, where it can be tracked into the home. I propose that lead from wheel weights contributes to the lead burden of urban populations.
Clinical characteristics of clear cell ovarian cancer: A retrospective multicenter experience of 308 patients in South Korea.
Authors: Hee Yeon Lee, Ji Hyung Hong, Jae Ho Byun, Hee Jun Kim, Sun Kyung Baek, Jin Young Kim, Ki Hyang Kim, Jina Yun, Jung A Kim, Kwonoh Park, Hyo Jin Lee, Jung Lim Lee, Young-Woong Won, Il-Hwan Kim, Woo Kyun Bae, Der Sheng Sun, Suee Lee, Min-Young Lee, Guk Jin Lee, Sook Hee Hong
Journal: Journal of Clinical Oncology (2019)

e17062 Background: Clear cell ovarian cancer is rare, accounts for about 3-10% of epithelial ovarian carcinoma, and is known to be associated with endometriosis. This tumor type has poor prognosis due to inherent chemoresistance. We investigated clinical characteristics and prognostic factors of clear cell ovarian cancer in South Korea. Methods: We reviewed the medical records of 308 patients with clear cell histology ovarian cancer who underwent debulking surgery from 21 institutions in South Korea between 1995 and 2015. Results: Mean age was 51 years (range, 25-81) and 194 patients (63.7%) had stage I disease, 34 (11.1%) had stage II, 66 (21.6%) had stage III, and 11 (3.6%) had stage IV. 107 patients (34.9%) had endometriosis. 9 patients (2.9%) received neoadjuvant chemotherapy, 248 (80.5%) received postoperative chemotherapy, and among them, 238 (96%) received taxane-platinum chemotherapy. 275 patients (89.3%) achieved optimal debulking. 112 patients (37%) had recurrence, 182 (59.1%) was disease-free, and 12 (3.9%) lost follow up. Median value of CA-125 was 72.34 U/ml (range, 1.9-8930), 45.7 in stage I, 98.9 in stage II, 192.1 in stage III, and 634.8 in stage IV. 1-year, and 3-year rate of disease-free survival (DFS) was 70%, and 63%, respectively. 1-yr DFS rate was 90% in stage Ia and Ib, 88% in stage Ic and II, and 60% in stage III and IV. According to the same stage grouping, 3-year DFS rate was 82%, 70%, and 40%, respectively. Overall survival (OS) rate at 1 year was 97%, 99%, and 90%, and 97%, 96%, and 88% at 3 year. Multivariate analysis revealed optimal debulking (HR 6.62, p &lt; 0.001) as a significant prognostic factor for DFS. Among the 94 patients with early stage (Ia and Ib), 17 patients (18.1%) received adjuvant chemotherapy, and there was no significant difference in DFS according to adjuvant chemotherapy (log rank p = 0.57). Conclusions: In patients with clear cell ovarian cancer, optimal debulking surgery was associated with improved DFS. And the role of adjuvant chemotherapy in early stage clear cell ovarian cancer is elusive and needs further study.
Randomized phase II study of sequential carboplatin/paclitaxel (CP) and gefitinib (G) in chemotherapy-naïve patients with advanced non-small-cell lung cancer (NSCLC): Final results
Authors: H. Nokihara, Y. Ohe, K. Yamada, M. Kawaishi, T. Kato, N. Yamamoto, I. Sekine, H. Kunitoh, N. Saijo, T. Tamura
Journal: Journal of Clinical Oncology (2008)

8069 Background: G has been shown to exhibit antitumor activity against NSCLC, however, the optimal timing of its administration remains unclear. We conducted a randomized phase II study of CP followed by G or G followed by CP in chemotherapy-naïve advanced NSCLC patients in order to select the candidate arm for a subsequent phase III study. Methods: Chemotherapy-naïve patients with histologically or cytologically confirmed NSCLC, stage IIIB or IV, aged between 20 to74 years, performance status 0–1, were randomized to either Arm A (carboplatin (AUC 6, day 1) plus paclitaxel (200 mg/m2, day 1) every 3 weeks for 4 courses followed by daily G (250 mg/day)) or Arm B (daily G until disease progression followed by CP every 3 weeks for 4 courses). The primary endpoint was overall survival, and the planned sample size for this randomized phase II study was 96 patients (Liu’s selection design for pilot studies on survival, Biometrics 49: 391–398, 1993). Results: From June 2003 to October 2005, 97 patients were enrolled, and 96 of these patients were treated in this study. Forty-nine patients (males/females: 28/21, median age: 63 years, adeno/non-adeno: 43/6, stageIII/IV: 11/38, smoker/non-smoker: 27/22) were randomized to Arm A and 48 patients (males/females: 28/20, median age: 61 years, adeno/non-adeno: 42/6, stageIII/IV: 11/37, smoker/non-smoker: 28/20) to Arm B. The response rate to CP in Arm A was 32.7% (16/49), and that to G in Arm B was 29.8% (14/47). The median survival times were 18.8 months and 17.2 months, and the 1-year survival rates were 61.2% and 68.1% in Arm A and arm B, respectively. One patient had died of treatment-related perforative peritonitis and two patients had developed interstitial lung disease. Conclusions: Although overall survival is similar in both arms, from both survival curves we select CP followed by G as the experimental arm for a subsequent phase III study. No significant financial relationships to disclose.
The Doctor Looks at Literature. Psychological Studies of Life and Letters.
Journal: JAMA (1923)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
The Cyclopedia of Medicine
Journal: JAMA (1934)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Section 38.—Viral Arthritis
Journal: JAMA (1973)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Obituaries
Authors: Eric Bernicker
Journal: JAMA (1989)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Selecting patients with metastatic colorectal cancer for treatment with temozolomide using proteomic analysis of MGMT
Authors: S. Schwartz, F. Cecchi, Y. Tian, K. Scott, M. Di Bartolomeo, F. Morano, G. Fucà, A. Martinetti, F. De Braud, F. Dominoni, M. Milione, M.A. Calegari, A. Orlandi, C. Barone, F. Pietrantonio, T. Hembrough
Journal: Annals of Oncology (2017)
La sécrétion interne du pancréas et l'insuline. Par André Choay, docteur en médecine, pharmacien, medaille d'or de l'internat des hôpitaux de Paris.
Journal: JAMA (1926)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Investigational Treatments: Process, Payment, and Priorities
Authors: Kimford J. Meador
Journal: JAMA (1997)

<h3>To the Editor.</h3> —In his article on investigational treatments, Dr Eddy<sup>1</sup>describes "the minimum evidence required to provide physicians and patients with the information they need to determine how the treatment will affect the patient's outcomes." In addition, he asserts that "denial of coverage is one of the few barriers that delays the dissemination of procedures, tests, and off-label uses of drugs before their effectiveness can be determined." Who should make these determinations? Eddy states that the evidence should be "sufficient to enable appropriately trained, motivated, and impartial people to draw conclusions about the magnitude of the effects." The determination of payment (ie, access) for standard treatments or tests that have proven efficacy, much less the determination of investigational status, is frequently in the purview of health insurance and health maintenance companies. These sources can hardly be deemed "impartial" and, in most states, are free of medicolegal liability for their decisions. In effect
Commentaire du travail de van Rhijn BD et al., pp. 1049
Journal: Endoscopy (2014)

See also: Evaluating the Endoscopic Reference Score for eosinophilic esophagitis: moderate to substantial intra- and interobserver reliabilityEndoscopy 2014; 46(12): 1049-1055DOI: 10.1055/s-0034-1377781
Bundle branch block carries a poor prognosis for patients presenting with acute coronary syndromes. Results from the prospective registry of acute ischaemic syndromes in the United Kingdom (PRAIS-UK) Ameet Bakhai, Marcelo C. Shibata, Julian R. Collinson, Diego Perez de Arenaza, Marcus D. Flather, Jaspal S. Kooner, Jennifer A. A. Adgey. Royal Brompton and Harefield NHS Trust Hospital, London, United Kingdom
Journal: Journal of the American College of Cardiology (2001)
Hypothermia
Authors: A. Armstrong
Journal: BMJ (1991)

and I believe we should be much readier to make proleptic appointments, up to a year before an anticipated vacancy occurs.This still allows competitive appointment-which has done much to maintain standards in the NHS-to be retained and allows the hospital the time to make a thought- ful choice after the issue of meaningful advertise- ments.For the chosen candidate this free period offers the chance to plan a personal educational programme to suit a specific situation, which can include the study of technological advances that seem particularly appropriate.However wide or restricted the field in which a special interest is pursued it is worth remembering the comment quoted by Griffen-"safety is not predicted on frequency of performance of an operation, but appears to be directly related to the adequacy of initial training."3
THE AMBITION OF THE OPTICIAN.
Journal: JAMA (1896)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
In This Issue
Journal: American Journal of Psychiatry (2013)

Swiss Army Reform Decreased SuicidesSuicides among Swiss men ages 18-43 declined after legislation halved the number of militia soldiers in 2003 and made it more difficult for soldiers to bring their weapons home after their discharge, thereby decreasing the number of army-issued firearms in homes.The decrease in suicide by shooting (figure) was only partially offset by suicides using other impulsive methods, primarily jumping in front of trains.Reisch et al. (p.977) calculate that approximately 30 fewer Swiss men in this age group died by suicide each year, and the lower rate persisted for several years.